PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS

PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS

Show other versions (1)

The definition of primary prevention of cardiovascular diseases is presented. Statins preventive value in patients without cardiovascular diseases is analyzed. Randomized controlled studies on primary prevention with statins are briefed. Therapeutic equivalence of statin generics with originator is...

Full description

Bibliographic Details
Main Authors:	S. Y. Martsevich, N. P. Kutishenko
Format:	Article
Language:	English
Published:	Столичная издательская компания 2016-01-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	primary prevention cardiovascular complications statins
Online Access:	https://www.rpcardio.online/jour/article/view/693

Similar Items

Statins in primary prevention: is the enthusiasm justified?
by: Arun K. Chopra, et al.
Published: (2020-07-01)

Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Interpretation of the U.S. Preventive Services Task Force Recommendation Statement
by: SHI Weili, LI Mingyan, DUAN Hongyan
Published: (2024-04-01)

Older adult preferences regarding benefits and harms of statin and aspirin therapy for cardiovascular primary prevention
by: Frances M. Wang, et al.
Published: (2023-03-01)

Statin Use and Eligibility for Primary Prevention of Atherosclerotic Cardiovascular Disease Among Adults at Borderline or Intermediate Risk in the United States
by: Michael M. Hammond, et al.
Published: (2023-04-01)

Statins in the primary prevention of cardiovascular disease. Rosuvastatin capabilities
by: Marina G. Bubnova, et al.
Published: (2021-06-01)

New clinical and pharmacological aspects of the use of atorvastatin for primary and secondary prevention of complications of cardiovascular diseases
by: S. R. Gilyarevsky, et al.
Published: (2018-09-01)

Multimorbidity and statin prescription for primary prevention of cardiovascular diseases: A cross-sectional study in general practice in France
by: Racha Onaisi, et al.
Published: (2023-01-01)

Applying the behavior change wheel to design de-implementation strategies to reduce low-value statin prescription in primary prevention of cardiovascular disease in primary care
by: Alvaro Sanchez, et al.
Published: (2022-10-01)

Appropriate Use of Primary Statin Preventive Therapy Among Patients with High Atherosclerosis-Related Cardiovascular Disease Risks: Cross-Sectional Study, Northeast Ethiopia
by: Melaku EE, et al.
Published: (2023-11-01)

Statin use in older people primary prevention on cardiovascular disease: an updated systematic review and meta-analysis
by: Hao Huang, et al.
Published: (2022-03-01)

PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

STATINS IN PREVENTION OF ISCHEMIC STROKE
by: A. V. Susekov, et al.
Published: (2015-09-01)

Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease
by: Hassan Saadati, et al.
Published: (2020-11-01)

Statins in primary prophylaxis of cardiovascular diseases
by: Zhanna Davidovna Kobalava, et al.
Published: (2011-09-01)

Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study
by: Henock G. Yebyo, et al.
Published: (2020-09-01)

Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly
by: Sydney B Long, et al.
Published: (2010-12-01)

Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts
by: Henock G. Yebyo, et al.
Published: (2018-05-01)

Time trends in the prescription of statins for the primary prevention of cardiovascular disease in the United Kingdom: a cohort study using The Health Improvement Network primary care data
by: O’Keeffe AG, et al.
Published: (2016-05-01)

ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT?
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
by: N. F. Puchin'yan, et al.
Published: (2015-12-01)

Do statins benefit low-risk population for primary prevention of atherosclerotic cardiovascular disease: A retrospective cohort study
by: In Sun Ryou, et al.
Published: (2022-11-01)

Statins in Healthy Adults: A Meta-Analysis
by: Lee Sandwith, et al.
Published: (2021-06-01)

STATIN GENERICS: EFFICACY AND SAFETY RATIO
by: V. P. Voronina, et al.
Published: (2016-01-01)

Use of statins in primary prevention of coronary artery disease: new data on risk-benefit balance
by: S. R. Gilyarevskiy, et al.
Published: (2013-12-01)

Impact of China’s Low Centralized Medicine Procurement Prices on the Cost-Effectiveness of Statins for the Primary Prevention of Atherosclerotic Cardiovascular Disease
by: Miao Wang, et al.
Published: (2020-06-01)

Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi‐Ethnic Study of Atherosclerosis)
by: Michael D. Miedema, et al.
Published: (2018-06-01)

Statin Treatment in Specific Patient Groups: Role for Improved Cardiovascular Risk Markers
by: Alyssa M. B. White, et al.
Published: (2020-11-01)

Correction of Hypercholesterolemia in Primary and Secondary Prevention of Cardiovascular Diseases: Features and Controversial Issues
by: N. M. Akhmedzhanov, et al.
Published: (2019-01-01)

PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE AND ANTIPLATELET THERAPY. CLINICAL LECTURE
by: L. O. Minushkina
Published: (2017-12-01)

The clinical and economic value of lovastatin in the primary prevention of cardiovascular disease
by: Lorenzo Pradelli, et al.
Published: (2006-09-01)

STATINS USE IN THE PERIOPERATIVE PERIOD ACCORDING TO THE EVIDENCE-BASED MEDICINE
by: V. V. Samoylenko, et al.
Published: (2015-09-01)

Effects of Statins for Primary Prevention in the Elderly: Recent Evidence
by: Kyu Kim, et al.
Published: (2020-01-01)

Prescribing pattern of statins for primary prevention of cardiovascular diseases in patients with type 2 diabetes: insights from Ethiopia
by: Gebre Teklemariam Demoz, et al.
Published: (2019-07-01)

Patients’ and health professionals’ attitudes and perceptions towards the initiation of preventive drugs for primary prevention of cardiovascular disease: a systematic review of qualitative studies
by: Olla Qadi, et al.
Published: (2020-10-01)

Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies
by: Kamal Awad, et al.
Published: (2021-06-01)

Holistic Approach in Follow-up of Individuals Living with HIV: Primary Cardiovascular Protection
by: Nursel ÇALIK BAŞARAN, et al.
Published: (2024-03-01)

Association of Primary Care Providers’ Beliefs of Statins for Primary Prevention and Statin Prescription
by: Jeffrey D. Clough, et al.
Published: (2019-02-01)

Aspirin and statins: possibilities for joint improvement of prognosis in cardiovascular disease
by: К. G. Pereverzeva, et al.
Published: (2019-01-01)

THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT DO PRACTICING PHYSICIANS THINK ABOUT IT?
by: S. Yu. Martsevich, et al.
Published: (2015-09-01)

Cost-effectiveness analysis of statins in primary care: results from the Arteris cohort study
by: Michel Romanens, et al.
Published: (2021-04-01)